{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:35:28Z","timestamp":1790976928229,"version":"4.1.0"},"reference-count":199,"publisher":"Harborside Press, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Thymomas and thymic carcinomas are rare mediastinal tumors that originate in the thymus. Patients with thymoma may experience symptoms associated with autoimmune paraneoplastic diseases (such as myasthenia gravis), which typically do not occur in patients with thymic carcinoma. The NCCN Guidelines for Thymomas and Thymic Carcinomas provide guidance for the diagnosis, treatment, and surveillance of patients with thymoma and thymic carcinoma. Involvement of a multidisciplinary team with experience treating thymomas and thymic carcinomas is highly recommended.<\/jats:p>","DOI":"10.6004\/jnccn.2025.0027","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:39:10Z","timestamp":1749631150000},"page":"255-269","source":"Crossref","is-referenced-by-count":41,"title":["Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology"],"prefix":"10.6004","volume":"23","author":[{"given":"Gregory J.","family":"Riely","sequence":"first","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Wood","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy W.","family":"Loo","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara L.","family":"Aisner","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallace","family":"Akerley","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute at the University of Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Bauman","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Bharat","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Y.","family":"Chang","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian R.","family":"Chirieac","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Brigham and Women\u2019s Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"DeCamp","sequence":"additional","affiliation":[{"name":"University of Wisconsin Carbone Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakash","family":"Desai","sequence":"additional","affiliation":[{"name":"O\u2019Neal Comprehensive Cancer Center at UAB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Dilling","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dowell","sequence":"additional","affiliation":[{"name":"UT Southwestern Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Durm","sequence":"additional","affiliation":[{"name":"Indiana University Melvin and Bren Simon Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Gettinger","sequence":"additional","affiliation":[{"name":"Yale Cancer Center\/Smilow Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis E.","family":"Grotz","sequence":"additional","affiliation":[{"name":"Mayo Clinic Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Gubens","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Juloori","sequence":"additional","affiliation":[{"name":"The UChicago Medicine Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy P.","family":"Lackner","sequence":"additional","affiliation":[{"name":"Fred & Pamela Buffett Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lanuti","sequence":"additional","affiliation":[{"name":"Mass General Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Lin","sequence":"additional","affiliation":[{"name":"University of Michigan Rogel Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Lovly","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Morgensztern","sequence":"additional","affiliation":[{"name":"Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trey C.","family":"Mullikin","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ng","sequence":"additional","affiliation":[{"name":"The University of Tennessee Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[{"name":"Mayo Clinic Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight H.","family":"Owen","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip P.","family":"Patel","sequence":"additional","affiliation":[{"name":"UC San Diego Moores Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Patil","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio M.","family":"Polanco","sequence":"additional","affiliation":[{"name":"UT Southwestern Simmons Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Riess","sequence":"additional","affiliation":[{"name":"UC Davis Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Johns Hopkins Kimmel Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Tam","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawee","family":"Tanvetyanon","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Yanagawa","sequence":"additional","affiliation":[{"name":"UCLA Jonsson Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Yang","sequence":"additional","affiliation":[{"name":"Johns Hopkins Kimmel Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Yau","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Gregory","sequence":"additional","affiliation":[{"name":"National Comprehensive Cancer Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hang","sequence":"additional","affiliation":[{"name":"National Comprehensive Cancer Network"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"J Thorac Oncol","first-page":"200","article-title":"The 2021 WHO Classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?","volume":"17","author":"Marx A","year":"2022","unstructured":"Marx A, Chan JKC, Chalabreysse L,  The 2021 WHO Classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol 2022;17:200\u2013213."},{"key":"B2","article-title":"Tumors of the Thymus","author":"Marx A","year":"2021","unstructured":"Marx A, Detterback F, Marom EM. Tumors of the Thymus. In: WHO Classification of Tumours Editorial Board. Thoracic Tumours: WHO Classification of Tumours, 5th ed. World Health Organization; 2021."},{"key":"B3","series-title":"J Thorac Oncol","first-page":"S260","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels EA","year":"2010","unstructured":"Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol 2010;5:S260\u2013265."},{"key":"B4","series-title":"Front Oncol","first-page":"1308989","article-title":"Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999\u20132019","volume":"13","author":"Gerber TS","year":"2023","unstructured":"Gerber TS, Strobl S, Marx A,  Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999\u20132019. Front Oncol 2023;13:1308989."},{"key":"B5","series-title":"Ann Thorac Surg","first-page":"878","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo K","year":"2003","unstructured":"Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878\u2013884; discussion 884\u2013885."},{"key":"B6","series-title":"J Thorac Oncol","first-page":"109","article-title":"Thymoma: a population-based study of the management and outcomes for the province of British Columbia","volume":"8","author":"Mariano C","year":"2013","unstructured":"Mariano C, Ionescu DN, Cheung WY,  Thymoma: a population-based study of the management and outcomes for the province of British Columbia. J Thorac Oncol 2013;8:109\u2013117."},{"key":"B7","series-title":"J Thorac Oncol","first-page":"S304","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka A","year":"2010","unstructured":"Masaoka A. Staging system of thymoma. J Thorac Oncol 2010;5:S304\u2013312."},{"key":"B8","series-title":"J Thorac Oncol","first-page":"S259","article-title":"Proceedings of the First International Conference on Thymic Malignancies. August 20\u201321, 2009. Bethesda, Maryland, USA","volume":"5","year":"2010","unstructured":"Proceedings of the First International Conference on Thymic Malignancies. August 20\u201321, 2009. Bethesda, Maryland, USA. J Thorac Oncol 2010;5:S259\u2013370."},{"key":"B9","series-title":"J Thorac Oncol","first-page":"1810","article-title":"Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging","volume":"9","author":"Litvak AM","year":"2014","unstructured":"Litvak AM, Woo K, Hayes S,  Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging. J Thorac Oncol 2014;9:1810\u20131815."},{"key":"B10","series-title":"J Thorac Cardiovasc Surg","first-page":"95","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad U","year":"2015","unstructured":"Ahmad U, Yao X, Detterbeck F,  Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg 2015;149:95\u2013100, 101.e1\u20132."},{"key":"B11","series-title":"J Thorac Oncol","first-page":"637","article-title":"Thymic carcinomas-a concise multidisciplinary update on recent developments from the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group","volume":"17","author":"Roden AC","year":"2022","unstructured":"Roden AC, Ahmad U, Cardillo G,  Thymic carcinomas-a concise multidisciplinary update on recent developments from the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group. J Thorac Oncol 2022;17:637\u2013650."},{"key":"B12","series-title":"Eur J Cardiothorac Surg","first-page":"1144","article-title":"Surgical treatment of thymoma: an 11-year experience with 761 patients","volume":"49","author":"Zhao Y","year":"2016","unstructured":"Zhao Y, Shi J, Fan L,  Surgical treatment of thymoma: an 11-year experience with 761 patients. Eur J Cardiothorac Surg 2016;49:1144\u20131149."},{"key":"B13","series-title":"J Thorac Cardiovasc Surg","first-page":"26","article-title":"Comparison of patterns of relapse in thymic carcinoma and thymoma","volume":"138","author":"Huang J","year":"2009","unstructured":"Huang J, Rizk NP, Travis WD,  Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 2009;138:26\u201331."},{"key":"B14","series-title":"Virchows Arch","first-page":"487","article-title":"Mesenchymal tumours of the mediastinum\u2013part I","volume":"467","author":"den Bakker MA","year":"2015","unstructured":"den Bakker MA, Marx A, Mukai K, Str\u00f6bel P. Mesenchymal tumours of the mediastinum\u2013part I. Virchows Arch 2015;467:487\u2013500."},{"key":"B15","series-title":"Eur J Radiol Open","first-page":"26","article-title":"Anterior mediastinal masses in the Framingham Heart study: prevalence and CT image characteristics","volume":"2","author":"Araki T","year":"2015","unstructured":"Araki T, Nishino M, Gao W,  Anterior mediastinal masses in the Framingham Heart study: prevalence and CT image characteristics. Eur J Radiol Open 2015;2:26\u201331."},{"key":"B16","series-title":"J Thorac Oncol","first-page":"S1724","article-title":"Policies and reporting guidelines for small biopsy specimens of mediastinal masses","volume":"6","author":"Marchevsky A","year":"2011","unstructured":"Marchevsky A, Marx A, Strobel P,  Policies and reporting guidelines for small biopsy specimens of mediastinal masses. J Thorac Oncol 2011;6:S1724\u20131729."},{"key":"B17","series-title":"Chest","first-page":"511","article-title":"Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum","volume":"112","author":"Strollo DC","year":"1997","unstructured":"Strollo DC, Rosado de Christenson ML, Jett JR. Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum. Chest 1997;112:511\u2013522."},{"key":"B18","series-title":"Chest","first-page":"1344","article-title":"Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum","volume":"112","author":"Strollo DC","year":"1997","unstructured":"Strollo DC, Rosado-de-Christenson ML, Jett JR. Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum. Chest 1997;112:1344\u20131357."},{"key":"B19","series-title":"J Thorac Dis","first-page":"173","article-title":"Thymic neoplasm: a rare disease with a complex clinical presentation","volume":"5","author":"Rashid OM","year":"2013","unstructured":"Rashid OM, Cassano AD, Takabe K. Thymic neoplasm: a rare disease with a complex clinical presentation. J Thorac Dis 2013;5:173\u2013183."},{"key":"B20","series-title":"Thorac Surg Clin","first-page":"59","article-title":"Management of stage I and II thymoma","volume":"21","author":"Detterbeck FC","year":"2011","unstructured":"Detterbeck FC, Parsons AM. Management of stage I and II thymoma. Thorac Surg Clin 2011;21:59\u201367, vi\u2013vii."},{"key":"B21","series-title":"Chin Med J (Engl)","first-page":"2186","article-title":"Thymoma: current diagnosis and treatment","volume":"126","author":"Detterbeck FC","year":"2013","unstructured":"Detterbeck FC, Zeeshan A. Thymoma: current diagnosis and treatment. Chin Med J (Engl) 2013;126:2186\u20132191."},{"key":"B22","article-title":"Anterior mediastinal mass","author":"Almeida P","unstructured":"Almeida P, Heller D. Anterior mediastinal mass. Accessed April 24, 2025. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546608\/"},{"key":"B23","series-title":"Lancet Oncol","first-page":"229","article-title":"Mediastinal (thymic) large B-cell lymphoma: where do we stand?","volume":"3","author":"Barth TFE","year":"2002","unstructured":"Barth TFE, Leith\u00e4user F, Joos S,  Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol 2002;3:229\u2013234."},{"key":"B24","series-title":"J Clin Endocrinol Metab","first-page":"2603","article-title":"Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series","volume":"90","author":"Ferolla P","year":"2005","unstructured":"Ferolla P, Falchetti A, Filosso P,  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 2005;90:2603\u20132609."},{"key":"B25","series-title":"J Intern Med","first-page":"501","article-title":"Thymic carcinoids in multiple endocrine neoplasia type 1","volume":"243","author":"Teh BT","year":"1998","unstructured":"Teh BT. Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med 1998;243:501\u2013504."},{"key":"B26","series-title":"Cancer","first-page":"681","article-title":"Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging","volume":"80","author":"Moran CA","year":"1997","unstructured":"Moran CA, Suster S. Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging. Cancer 1997;80:681\u2013690."},{"key":"B27","series-title":"Adv Anat Pathol","first-page":"69","article-title":"Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations","volume":"14","author":"McKenney JK","year":"2007","unstructured":"McKenney JK, Heerema-McKenney A, Rouse RV. Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations. Adv Anat Pathol 2007;14:69\u201392."},{"key":"B28","series-title":"Jpn J Clin Oncol","first-page":"1119","article-title":"JLCS medical practice guidelines for thymic tumors: summary of recommendations","volume":"47","author":"Yokoi K","year":"2017","unstructured":"Yokoi K, Kondo K, Fujimoto K,  JLCS medical practice guidelines for thymic tumors: summary of recommendations. Jpn J Clin Oncol 2017;47:1119\u20131122."},{"key":"B29","series-title":"Mediastinum","first-page":"28","article-title":"Imaging evaluation of thymic tumors","volume":"7","author":"Strange CD","year":"2023","unstructured":"Strange CD, Truong MT, Ahuja J,  Imaging evaluation of thymic tumors. Mediastinum 2023;7:28."},{"key":"B30","series-title":"Front Oncol","first-page":"810419","article-title":"Imaging evaluation of thymoma and thymic carcinoma","volume":"11","author":"Strange CD","year":"2021","unstructured":"Strange CD, Ahuja J, Shroff GS,  Imaging evaluation of thymoma and thymic carcinoma. Front Oncol 2021;11:810419."},{"key":"B31","series-title":"Cancer Imaging","first-page":"440","article-title":"Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board: (part 2 of 2 part series)","volume":"13","author":"Quint LE","year":"2013","unstructured":"Quint LE, Reddy RM, Lin J,  Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board: (part 2 of 2 part series). Cancer Imaging 2013;13:440\u2013447."},{"key":"B32","series-title":"J Thorac Oncol","first-page":"S1717","article-title":"Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma","volume":"6","author":"Marom EM","year":"2011","unstructured":"Marom EM, Rosado-de-Christenson ML, Bruzzi JF,  Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma. J Thorac Oncol 2011;6:S1717\u20131723."},{"key":"B33","series-title":"J Thorac Oncol","first-page":"S296","article-title":"Imaging thymoma","volume":"5","author":"Marom EM","year":"2010","unstructured":"Marom EM. Imaging thymoma. J Thorac Oncol 2010;5:S296\u2013303."},{"key":"B34","series-title":"Top Magn Reson Imaging","first-page":"65","article-title":"MR imaging of thymic epithelial neoplasms","volume":"27","author":"Carter BW","year":"2018","unstructured":"Carter BW, Lichtenberger JP, Benveniste MF. MR imaging of thymic epithelial neoplasms. Top Magn Reson Imaging 2018;27:65\u201371."},{"key":"B35","series-title":"J Thorac Oncol","first-page":"S102","article-title":"Approaching the patient with an anterior mediastinal mass: a guide for clinicians","volume":"9","author":"Carter BW","year":"2014","unstructured":"Carter BW, Marom EM, Detterbeck FC. Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol 2014;9:S102\u2013109."},{"key":"B36","series-title":"Am J Clin Pathol","first-page":"444","article-title":"Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema","volume":"137","author":"Moran CA","year":"2012","unstructured":"Moran CA, Weissferdt A, Kalhor N,  Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol 2012;137:444\u2013450."},{"key":"B37","series-title":"J Thorac Oncol","first-page":"S1710","article-title":"The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck FC","year":"2011","unstructured":"Detterbeck FC, Nicholson AG, Kondo K,  The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol 2011;6:S1710\u20131716."},{"key":"B38","series-title":"J Thorac Oncol","first-page":"S1691","article-title":"Standard outcome measures for thymic malignancies","volume":"6","author":"Huang J","year":"2011","unstructured":"Huang J, Detterbeck FC, Wang Z, Loehrer PJ. Standard outcome measures for thymic malignancies. J Thorac Oncol 2011;6:S1691\u20131697."},{"key":"B39","series-title":"Am J Clin Pathol","first-page":"451","article-title":"Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment","volume":"137","author":"Moran CA","year":"2012","unstructured":"Moran CA, Walsh G, Suster S, Kaiser L. Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol 2012;137:451\u2013461."},{"key":"B40","series-title":"J Thorac Oncol","first-page":"S352","article-title":"Tumor-node metastasis staging system for thymic epithelial tumors","volume":"5","author":"Kondo K","year":"2010","unstructured":"Kondo K. Tumor-node metastasis staging system for thymic epithelial tumors. J Thorac Oncol 2010;5:S352\u2013356."},{"key":"B41","series-title":"Cancer","first-page":"2485","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka A","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485\u20132492."},{"key":"B42","series-title":"Radiol Clin North Am","first-page":"183","article-title":"Thymic epithelial neoplasms: Tumor-Node-Metastasis staging","volume":"59","author":"Benveniste MFK","year":"2021","unstructured":"Benveniste MFK, Betancourt Cuellar SL, Carter BW,  Thymic epithelial neoplasms: Tumor-Node-Metastasis staging. Radiol Clin North Am 2021;59:183\u2013192."},{"key":"B43","series-title":"AJCC Cancer Staging Manual","first-page":"1","author":"Amin MB","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL,  AJCC Cancer Staging Manual, 8th edition. Springer International Publishing; 2017:1\u20131032."},{"key":"B44","series-title":"Radiographics","first-page":"758","article-title":"IASLC\/ITMIG staging system and lymph node map for thymic epithelial neoplasms","volume":"37","author":"Carter BW","year":"2017","unstructured":"Carter BW, Benveniste MF, Madan R,  IASLC\/ITMIG staging system and lymph node map for thymic epithelial neoplasms. Radiographics 2017;37:758\u2013776."},{"key":"B45","series-title":"J Thorac Oncol","first-page":"1571","article-title":"Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors","volume":"12","author":"Meurgey A","year":"2017","unstructured":"Meurgey A, Girard N, Merveilleux Du Vignaux C,  Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors. J Thorac Oncol 2017;12:1571\u20131581."},{"key":"B46","series-title":"J Thorac Oncol","first-page":"S65","article-title":"The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Detterbeck FC","year":"2014","unstructured":"Detterbeck FC, Stratton K, Giroux D,  The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014;9:S65\u201372."},{"key":"B47","series-title":"Am J Surg Pathol","first-page":"427","article-title":"Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis","volume":"39","author":"Roden AC","year":"2015","unstructured":"Roden AC, Yi ES, Jenkins SM,  Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis. Am J Surg Pathol 2015;39:427\u2013441."},{"key":"B48","series-title":"Eur J Cardiothorac Surg","first-page":"574","article-title":"Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group","volume":"49","author":"Fukui T","year":"2016","unstructured":"Fukui T, Fukumoto K, Okasaka T,  Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group. Eur J Cardiothorac Surg 2016;49:574\u2013579."},{"key":"B49","series-title":"J Thorac Oncol","first-page":"S88","article-title":"The ITMIG\/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM Classification of malignant tumors","volume":"9","author":"Bhora FY","year":"2014","unstructured":"Bhora FY, Chen DJ, Detterbeck FC,  The ITMIG\/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM Classification of malignant tumors. J Thorac Oncol 2014;9:S88\u201396."},{"key":"B50","series-title":"Ann Thorac Surg","first-page":"975","article-title":"The Society of Thoracic Surgeons expert consensus document on the surgical management of thymomas","volume":"118","author":"Liou DZ","year":"2024","unstructured":"Liou DZ, Berry MF, Brown LM,  The Society of Thoracic Surgeons expert consensus document on the surgical management of thymomas. Ann Thorac Surg 2024;118:975\u20131004."},{"key":"B51","series-title":"Interact Cardiovasc Thorac Surg","first-page":"399","article-title":"Is thymomectomy equivalent to complete thymectomy in non-myasthenic patients with early-stage thymoma?","volume":"28","author":"Fiorelli A","year":"2019","unstructured":"Fiorelli A, Natale G, Freda C, Santini M. Is thymomectomy equivalent to complete thymectomy in non-myasthenic patients with early-stage thymoma? Interact Cardiovasc Thorac Surg 2019;28:399\u2013403."},{"key":"B52","series-title":"J Med Invest","first-page":"17","article-title":"Optimal therapy for thymoma","volume":"55","author":"Kondo K","year":"2008","unstructured":"Kondo K. Optimal therapy for thymoma. J Med Invest 2008;55:17\u201328."},{"key":"B53","series-title":"Ann Thorac Surg","first-page":"1860","article-title":"Thymic tumors","volume":"77","author":"Detterbeck FC","year":"2004","unstructured":"Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860\u20131869."},{"key":"B54","series-title":"J Thorac Cardiovasc Surg","first-page":"376","article-title":"Prognostic factors and long-term results after thymoma resection: a series of 307 patients","volume":"112","author":"Regnard JF","year":"1996","unstructured":"Regnard JF, Magdeleinat P, Dromer C,  Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376\u2013384."},{"key":"B55","series-title":"J Thorac Cardiovasc Surg","first-page":"1134","article-title":"Thymoma: a clinicopathologic study based on the new World Health Organization classification","volume":"126","author":"Nakagawa K","year":"2003","unstructured":"Nakagawa K, Asamura H, Matsuno Y,  Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003;126:1134\u20131140."},{"key":"B56","series-title":"Eur J Cardiothorac Surg","first-page":"412","article-title":"Long-term survival and prognostic factors in thymic epithelial tumours","volume":"26","author":"Rea F","year":"2004","unstructured":"Rea F, Marulli G, Girardi R,  Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 2004;26:412\u2013418."},{"key":"B57","series-title":"J Thorac Oncol","first-page":"S1698","article-title":"A review of prognostic factors in thymic malignancies","volume":"6","author":"Detterbeck F","year":"2011","unstructured":"Detterbeck F, Youssef S, Ruffini E, Okumura M. A review of prognostic factors in thymic malignancies. J Thorac Oncol 2011;6:S1698\u20131704."},{"key":"B58","series-title":"Eur J Cardiothorac Surg","first-page":"361","article-title":"Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database","volume":"46","author":"Ruffini E","year":"2014","unstructured":"Ruffini E, Detterbeck F, Van Raemdonck D,  Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg 2014;46:361\u2013368."},{"key":"B59","series-title":"J Thorac Oncol","first-page":"S323","article-title":"Induction therapy for locally advanced thymoma","volume":"5","author":"Riely GJ","year":"2010","unstructured":"Riely GJ, Huang J. Induction therapy for locally advanced thymoma. J Thorac Oncol 2010;5:S323\u2013326."},{"key":"B60","series-title":"Lung Cancer","first-page":"369","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim ES","year":"2004","unstructured":"Kim ES, Putnam JB, Komaki R,  Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 2004;44:369\u2013379."},{"key":"B61","series-title":"Br J Cancer","first-page":"6","article-title":"A phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh H","year":"2010","unstructured":"Kunitoh H, Tamura T, Shibata T,  A phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606). Br J Cancer 2010;103:6\u201311."},{"key":"B62","series-title":"Ann Thorac Surg","first-page":"1848","article-title":"A meta-analysis of induction therapy for advanced thymic epithelial tumors","volume":"99","author":"Hamaji M","year":"2015","unstructured":"Hamaji M, Ali SO, Burt BM. A meta-analysis of induction therapy for advanced thymic epithelial tumors. Ann Thorac Surg 2015;99:1848\u20131856."},{"key":"B63","series-title":"Interact Cardiovasc Thorac Surg","first-page":"494","article-title":"Does surgical debulking for advanced stages of thymoma improve survival?","volume":"15","author":"Attaran S","year":"2012","unstructured":"Attaran S, Acharya M, Anderson JR, Punjabi PP. Does surgical debulking for advanced stages of thymoma improve survival? Interact Cardiovasc Thorac Surg 2012;15:494\u2013497."},{"key":"B64","series-title":"Ann Thorac Surg","first-page":"299","article-title":"Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients","volume":"95","author":"Weksler B","year":"2013","unstructured":"Weksler B, Dhupar R, Parikh V,  Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg 2013;95:299\u2013303."},{"key":"B65","series-title":"Thorac Surg Clin","first-page":"93","article-title":"Stage IVA thymoma: patterns of spread and surgical management","volume":"21","author":"Wright CD","year":"2011","unstructured":"Wright CD. Stage IVA thymoma: patterns of spread and surgical management. Thorac Surg Clin 2011;21:93\u201397, vii."},{"key":"B66","series-title":"J Thorac Oncol","first-page":"S344","article-title":"Extended resections for thymic malignancies","volume":"5","author":"Wright CD","year":"2010","unstructured":"Wright CD. Extended resections for thymic malignancies. J Thorac Oncol 2010;5:S344\u2013347."},{"key":"B67","series-title":"J Thorac Cardiovasc Surg","first-page":"1477","article-title":"Feasibility of multimodality therapy including extended resections in stage IVA thymoma","volume":"134","author":"Huang J","year":"2007","unstructured":"Huang J, Rizk NP, Travis WD,  Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 2007;134:1477\u20131483; discussion 1483\u20131484."},{"key":"B68","article-title":"Protocol for the examination of specimens from patients with thymic tumors","author":"Raparia K","unstructured":"Raparia K, Schneider F, Roden A, Dacic S. Protocol for the examination of specimens from patients with thymic tumors. Accessed May 5, 2025. Available at: https:\/\/documents.cap.org\/protocols\/Thymus_5.0.0.0.REL.CAPCP.pdf"},{"key":"B69","series-title":"J Thorac Cardiovasc Surg","first-page":"694","article-title":"Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection","volume":"141","author":"Pennathur A","year":"2011","unstructured":"Pennathur A, Qureshi I, Schuchert MJ,  Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg 2011;141:694\u2013701."},{"key":"B70","series-title":"J Thorac Cardiovasc Surg","first-page":"1599","article-title":"Surgical techniques for early-stage thymoma: video-assisted thoracoscopic thymectomy versus transsternal thymectomy","volume":"147","author":"Ye B","year":"2014","unstructured":"Ye B, Tantai JC, Ge XX,  Surgical techniques for early-stage thymoma: video-assisted thoracoscopic thymectomy versus transsternal thymectomy. J Thorac Cardiovasc Surg 2014;147:1599\u20131603."},{"key":"B71","series-title":"J Thorac Cardiovasc Surg","first-page":"1230","article-title":"Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma","volume":"148","author":"Sakamaki Y","year":"2014","unstructured":"Sakamaki Y, Oda T, Kanazawa G,  Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma. J Thorac Cardiovasc Surg 2014;148:1230\u20131237.e1."},{"key":"B72","series-title":"Eur J Cardiothorac Surg","first-page":"e187","article-title":"Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma","volume":"45","author":"Manoly I","year":"2014","unstructured":"Manoly I, Whistance RN, Sreekumar R,  Early and mid-term outcomes of trans-sternal and video-assisted thoracoscopic surgery for thymoma. Eur J Cardiothorac Surg 2014;45:e187\u2013193."},{"key":"B73","series-title":"Ann Surg Oncol","first-page":"322","article-title":"Video-assisted thoracoscopic surgical thymectomy to treat early thymoma: a comparison with the conventional transsternal approach","volume":"21","author":"Liu TJ","year":"2014","unstructured":"Liu TJ, Lin MW, Hsieh MS,  Video-assisted thoracoscopic surgical thymectomy to treat early thymoma: a comparison with the conventional transsternal approach. Ann Surg Oncol 2014;21:322\u2013328."},{"key":"B74","series-title":"J Thorac Oncol","first-page":"30","article-title":"Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta- analysis","volume":"11","author":"Friedant AJ","year":"2016","unstructured":"Friedant AJ, Handorf EA, Su S, Scott WJ. Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta- analysis. J Thorac Oncol 2016;11:30\u201338."},{"key":"B75","series-title":"J Thorac Oncol","first-page":"129","article-title":"Determinants of complete resection of thymoma by minimally invasive and open thymectomy: analysis of an international registry","volume":"12","author":"Burt BM","year":"2017","unstructured":"Burt BM, Yao X, Shrager J,  Determinants of complete resection of thymoma by minimally invasive and open thymectomy: analysis of an international registry. J Thorac Oncol 2017;12:129\u2013136."},{"key":"B76","series-title":"Ann Thorac Surg","first-page":"974","article-title":"Minimally invasive thymectomy and open thymectomy: outcome analysis of 263 patients","volume":"94","author":"Jurado J","year":"2012","unstructured":"Jurado J, Javidfar J, Newmark A,  Minimally invasive thymectomy and open thymectomy: outcome analysis of 263 patients. Ann Thorac Surg 2012;94:974\u2013981; discussion 981\u2013982."},{"key":"B77","series-title":"Ann Cardiothorac Surg","first-page":"1","article-title":"Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes","volume":"5","author":"Hess NR","year":"2016","unstructured":"Hess NR, Sarkaria IS, Pennathur A,  Minimally invasive versus open thymectomy: a systematic review of surgical techniques, patient demographics, and perioperative outcomes. Ann Cardiothorac Surg 2016;5:1\u20139."},{"key":"B78","series-title":"J Thorac Cardiovasc Surg","first-page":"555","article-title":"A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma","volume":"160","author":"Yang CJ","year":"2020","unstructured":"Yang CJ, Hurd J, Shah SA,  A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma. J Thorac Cardiovasc Surg 2020;160:555\u2013567.e15."},{"key":"B79","series-title":"Eur J Cardiothorac Surg","first-page":"ezac159","article-title":"A national analysis of open versus minimally invasive thymectomy for stage I\u2013III thymic carcinoma","volume":"62","author":"Hurd J","year":"2022","unstructured":"Hurd J, Haridas C, Potter A,  A national analysis of open versus minimally invasive thymectomy for stage I\u2013III thymic carcinoma. Eur J Cardiothorac Surg 2022;62:ezac159."},{"key":"B80","series-title":"Eur J Cardiothorac Surg","first-page":"1037","article-title":"Video-assisted thoracoscopic surgery versus open surgery for Stage I thymic epithelial tumours: a propensity score-matched study","volume":"54","author":"Gu Z","year":"2018","unstructured":"Gu Z, Chen C, Wang Y,  Video-assisted thoracoscopic surgery versus open surgery for Stage I thymic epithelial tumours: a propensity score-matched study. Eur J Cardiothorac Surg 2018;54:1037\u20131044."},{"key":"B81","series-title":"Ann Cardiothorac Surg","first-page":"519","article-title":"Minimally invasive thymectomy: the Mayo Clinic experience","volume":"4","author":"Rowse PG","year":"2015","unstructured":"Rowse PG, Roden AC, Corl FM,  Minimally invasive thymectomy: the Mayo Clinic experience. Ann Cardiothorac Surg 2015;4:519\u2013526."},{"key":"B82","series-title":"Ann Cardiothorac Surg","first-page":"495","article-title":"Video-assisted thoracoscopic surgery versus open thymectomy for thymoma: a systematic review","volume":"4","author":"Xie A","year":"2015","unstructured":"Xie A, Tjahjono R, Phan K, Yan TD. Video-assisted thoracoscopic surgery versus open thymectomy for thymoma: a systematic review. Ann Cardiothorac Surg 2015;4:495\u2013508."},{"key":"B83","series-title":"Ann Surg Oncol","first-page":"1371","article-title":"Long-term outcomes after thoracoscopic resection of stage I and II thymoma: a propensity-matched study","volume":"22","author":"Chao YK","year":"2015","unstructured":"Chao YK, Liu YH, Hsieh MJ,  Long-term outcomes after thoracoscopic resection of stage I and II thymoma: a propensity-matched study. Ann Surg Oncol 2015;22:1371\u20131376."},{"key":"B84","series-title":"Eur J Cardiothorac Surg","first-page":"ezac238","article-title":"Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases","volume":"62","author":"Hwang SK","year":"2022","unstructured":"Hwang SK, Lee GD, Kang CH,  Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases. Eur J Cardiothorac Surg 2022;62:ezac238."},{"key":"B85","series-title":"Ann Thorac Surg","first-page":"1047","article-title":"Video-assisted thoracic surgery thymectomy versus sternotomy thymectomy in patients with thymoma","volume":"104","author":"Agatsuma H","year":"2017","unstructured":"Agatsuma H, Yoshida K, Yoshino I,  Video-assisted thoracic surgery thymectomy versus sternotomy thymectomy in patients with thymoma. Ann Thorac Surg 2017;104:1047\u20131053."},{"key":"B86","series-title":"Eur J Surg Oncol","first-page":"1720","article-title":"Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: a meta-analysis","volume":"42","author":"Yang Y","year":"2016","unstructured":"Yang Y, Dong J, Huang Y. Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: a meta-analysis. Eur J Surg Oncol 2016;42:1720\u20131728."},{"key":"B87","series-title":"Eur J Cardiothorac Surg","first-page":"ezae346","article-title":"Robotic-assisted versus video-assisted thoracoscopic surgery for thymic epithelial tumours, from the European Society of Thoracic Surgeons Database","volume":"66","author":"Patel AJ","year":"2024","unstructured":"Patel AJ, Smith A, Ruffini E,  Robotic-assisted versus video-assisted thoracoscopic surgery for thymic epithelial tumours, from the European Society of Thoracic Surgeons Database. Eur J Cardiothorac Surg 2024;66:ezae346."},{"key":"B88","series-title":"J Thorac Oncol","first-page":"S1743","article-title":"Radiation therapy definitions and reporting guidelines for thymic malignancies","volume":"6","author":"Gomez D","year":"2011","unstructured":"Gomez D, Komaki R, Yu J,  Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol 2011;6:S1743\u20131748."},{"key":"B89","series-title":"J Thorac Oncol","first-page":"734","article-title":"The impact of postoperative radiotherapy for thymoma and thymic carcinoma","volume":"12","author":"Jackson MW","year":"2017","unstructured":"Jackson MW, Palma DA, Camidge DR,  The impact of postoperative radiotherapy for thymoma and thymic carcinoma. J Thorac Oncol 2017;12:734\u2013744."},{"key":"B90","series-title":"J Thorac Oncol","first-page":"1785","article-title":"Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the International Thymic Malignancies Interest Group Retrospective database","volume":"11","author":"Rimner A","year":"2016","unstructured":"Rimner A, Yao X, Huang J,  Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the International Thymic Malignancies Interest Group Retrospective database. J Thorac Oncol 2016;11:1785\u20131792."},{"key":"B91","series-title":"Ann Thorac Surg","first-page":"1635","article-title":"Comparison of stages I\u2013II thymoma treated by complete resection with or without adjuvant radiation","volume":"76","author":"Singhal S","year":"2003","unstructured":"Singhal S, Shrager JB, Rosenthal DI,  Comparison of stages I\u2013II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635\u20131641; discussion 1641\u20131642."},{"key":"B92","series-title":"Int J Radiat Oncol Biol Phys","first-page":"440","article-title":"Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease","volume":"76","author":"Forquer JA","year":"2010","unstructured":"Forquer JA, Rong N, Fakiris AJ,  Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys 2010;76:440\u2013445."},{"key":"B93","series-title":"Cancer","first-page":"5413","article-title":"Postoperative radiation therapy after complete resection of thymoma has little impact on survival","volume":"115","author":"Utsumi T","year":"2009","unstructured":"Utsumi T, Shiono H, Kadota Y,  Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer 2009;115:5413\u20135420."},{"key":"B94","series-title":"Ann Thorac Surg","first-page":"1641","article-title":"Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis","volume":"87","author":"Korst RJ","year":"2009","unstructured":"Korst RJ, Kansler AL, Christos PJ, Mandal S. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 2009;87:1641\u20131647."},{"key":"B95","series-title":"Int J Radiat Oncol Biol Phys","first-page":"98","article-title":"Intensity modulated radiation therapy plus etoposide\/cisplatin for patients with limited advanced unresectable thymic epithelial tumors: a prospective phase 2 study","volume":"107","author":"Fan XW","year":"2020","unstructured":"Fan XW, Yang Y, Wang HB,  Intensity modulated radiation therapy plus etoposide\/cisplatin for patients with limited advanced unresectable thymic epithelial tumors: a prospective phase 2 study. Int J Radiat Oncol Biol Phys 2020;107:98\u2013105."},{"key":"B96","series-title":"Chang Gung Med J","first-page":"515","article-title":"Concurrent chemoradiotherapy for unresectable thymic carcinoma","volume":"27","author":"Chen YY","year":"2004","unstructured":"Chen YY, Huang CH, Tang Y, Eng HL. Concurrent chemoradiotherapy for unresectable thymic carcinoma. Chang Gung Med J 2004;27:515\u2013522."},{"key":"B97","series-title":"JAMA Oncol","first-page":"971","article-title":"American Radium Society Appropriate Use Criteria for radiation therapy in the multidisciplinary management of thymic carcinoma","volume":"9","author":"Chun SG","year":"2023","unstructured":"Chun SG, Rimner A, Amini A,  American Radium Society Appropriate Use Criteria for radiation therapy in the multidisciplinary management of thymic carcinoma. JAMA Oncol 2023;9:971\u2013980."},{"key":"B98","series-title":"J Thorac Dis","first-page":"705","article-title":"Outcome of nonsurgical treatment for locally advanced thymic tumors","volume":"8","author":"Wang CL","year":"2016","unstructured":"Wang CL, Gao LT, Lv CX,  Outcome of nonsurgical treatment for locally advanced thymic tumors. J Thorac Dis 2016;8:705\u2013710."},{"key":"B99","series-title":"J Thorac Oncol","first-page":"S336","article-title":"Technical advances of radiation therapy for thymic malignancies","volume":"5","author":"Gomez D","year":"2010","unstructured":"Gomez D, Komaki R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol 2010;5:S336\u2013343."},{"key":"B100","series-title":"Int J Radiat Oncol Biol Phys","first-page":"9","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for intensity-modulated radiation therapy (IMRT)","volume":"73","author":"Hartford AC","year":"2009","unstructured":"Hartford AC, Palisca MG, Eichler TJ,  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 2009;73:9\u201314."},{"key":"B101","series-title":"Med Phys","first-page":"5067","article-title":"Safety considerations for IMRT: executive summary","volume":"38","author":"Moran JM","year":"2011","unstructured":"Moran JM, Dempsey M, Eisbruch A,  Safety considerations for IMRT: executive summary. Med Phys 2011;38:5067\u20135072."},{"key":"B102","series-title":"Cancer Radiother","first-page":"555","article-title":"State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83)","volume":"15","author":"Gregoire V","year":"2011","unstructured":"Gregoire V, Mackie TR. State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radiother 2011;15:555\u2013559."},{"key":"B103","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1311","article-title":"American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments","volume":"74","author":"Holmes T","year":"2009","unstructured":"Holmes T, Das R, Low D,  American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. Int J Radiat Oncol Biol Phys 2009;74:1311\u20131318."},{"key":"B104","article-title":"ATC Guidelines for the use of IMRT (including intra-thoracic treatments)","unstructured":"Advanced Technology Consortium. ATC Guidelines for the use of IMRT (including intra-thoracic treatments). Accessed May 6, 2025. Available at: http:\/\/rrp.cancer.gov\/content\/docs\/imrt.doc"},{"key":"B105","series-title":"J ICRU","first-page":"NP","article-title":"ICRU Report 83, prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT)","volume":"10","year":"2010","unstructured":"ICRU Report 83, prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT). J ICRU 2010;10:NP."},{"key":"B106","series-title":"Semin Radiat Oncol","first-page":"108","article-title":"Physical models and simpler dosimetric descriptors of radiation late toxicity","volume":"17","author":"Kong FM","year":"2007","unstructured":"Kong FM, Pan C, Eisbruch A, Ten Haken RK. Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol 2007;17:108\u2013120."},{"key":"B107","series-title":"Semin Radiat Oncol","first-page":"131","article-title":"Normal tissue tolerance dose metrics for radiation therapy of major organs","volume":"17","author":"Milano MT","year":"2007","unstructured":"Milano MT, Constine LS, Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007;17:131\u2013140."},{"key":"B108","series-title":"Int J Part Ther","first-page":"65","article-title":"Proton beam therapy for thymic carcinoma with pericardial involvement","volume":"7","author":"Loap P","year":"2021","unstructured":"Loap P, Scher N, Goudjil F,  Proton beam therapy for thymic carcinoma with pericardial involvement. Int J Part Ther 2021;7:65\u201370."},{"key":"B109","series-title":"Clin Lung Cancer","first-page":"362","article-title":"Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities","volume":"17","author":"Parikh RR","year":"2016","unstructured":"Parikh RR, Rhome R, Hug E,  Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities. Clin Lung Cancer 2016;17:362\u2013366."},{"key":"B110","series-title":"Radiother Oncol","first-page":"504","article-title":"Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: early response and toxicity assessment","volume":"118","author":"Vogel J","year":"2016","unstructured":"Vogel J, Berman AT, Lin L,  Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: early response and toxicity assessment. Radiother Oncol 2016;118:504\u2013509."},{"key":"B111","series-title":"Cryobiology","first-page":"170","article-title":"Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patients","volume":"67","author":"Zhang Z","year":"2013","unstructured":"Zhang Z, Wu B, Niu L,  Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patients. Cryobiology 2013;67:170\u2013174."},{"key":"B112","series-title":"J Vasc Interv Radiol","first-page":"709","article-title":"Percutaneous cryoablation for the treatment of recurrent thymoma: preliminary safety and efficacy","volume":"26","author":"Abtin F","year":"2015","unstructured":"Abtin F, Suh RD, Nasehi L,  Percutaneous cryoablation for the treatment of recurrent thymoma: preliminary safety and efficacy. J Vasc Interv Radiol 2015;26:709\u2013714."},{"key":"B113","series-title":"Eur Respir Rev","first-page":"75","article-title":"Thymic epithelial tumours: from basic principles to individualised treatment strategies","volume":"22","author":"Girard N","year":"2013","unstructured":"Girard N. Thymic epithelial tumours: from basic principles to individualised treatment strategies. Eur Respir Rev 2013;22:75\u201387."},{"key":"B114","series-title":"Mediastinum","first-page":"24","article-title":"Systemic treatments for thymic tumors: a narrative review","volume":"5","author":"Zucali PA","year":"2021","unstructured":"Zucali PA, De Vincenzo F, Perrino M,  Systemic treatments for thymic tumors: a narrative review. Mediastinum 2021;5:24."},{"key":"B115","series-title":"J Thorac Oncol","first-page":"299","article-title":"Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a systematic review","volume":"18","author":"Falkson CB","year":"2023","unstructured":"Falkson CB, Vella ET, Ellis PM,  Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a systematic review. J Thorac Oncol 2023;18:299\u2013312."},{"key":"B116","series-title":"Ann Thorac Surg","first-page":"961","article-title":"Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database","volume":"100","author":"Yamada Y","year":"2015","unstructured":"Yamada Y, Yoshino I, Nakajima J,  Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database. Ann Thorac Surg 2015;100:961\u2013967."},{"key":"B117","series-title":"J Clin Oncol","first-page":"4820","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"Kelly RJ","year":"2011","unstructured":"Kelly RJ, Petrini I, Rajan A,  Thymic malignancies: from clinical management to targeted therapies. J Clin Oncol 2011;29:4820\u20134827."},{"key":"B118","series-title":"J Thorac Oncol","first-page":"S119","article-title":"A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria","volume":"9","author":"Benveniste MF","year":"2014","unstructured":"Benveniste MF, Korst RJ, Rajan A,  A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol 2014;9:S119\u2013124."},{"key":"B119","series-title":"J Thorac Oncol","first-page":"108","article-title":"Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations","volume":"11","author":"Hwang Y","year":"2016","unstructured":"Hwang Y, Park IK, Park S,  Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations. J Thorac Oncol 2016;11:108\u2013114."},{"key":"B120","series-title":"Cancer","first-page":"2727","article-title":"Thymoma. A clinicopathologic review","volume":"60","author":"Lewis JE","year":"1987","unstructured":"Lewis JE, Wick MR, Scheithauer BW,  Thymoma. A clinicopathologic review. Cancer 1987;60:2727\u20132743."},{"key":"B121","series-title":"J Thorac Oncol","first-page":"436","article-title":"Paraneoplastic syndromes and thymic malignancies: an examination of the International Thymic Malignancy Interest Group retrospective database","volume":"13","author":"Padda SK","year":"2018","unstructured":"Padda SK, Yao X, Antonicelli A,  Paraneoplastic syndromes and thymic malignancies: an examination of the International Thymic Malignancy Interest Group retrospective database. J Thorac Oncol 2018;13:436\u2013446."},{"key":"B122","series-title":"Autoimmun Rev","first-page":"82","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard C","year":"2016","unstructured":"Bernard C, Frih H, Pasquet F,  Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev 2016;15:82\u201392."},{"key":"B123","series-title":"J Clin Oncol","first-page":"2280","article-title":"Thymoma: state of the art","volume":"17","author":"Thomas CR","year":"1999","unstructured":"Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol 1999;17:2280\u20132289."},{"key":"B124","series-title":"Autoimmune Dis","first-page":"847393","article-title":"Myasthenia gravis: a review of available treatment approaches","volume":"2011","author":"Gilhus NE","year":"2011","unstructured":"Gilhus NE, Owe JF, Hoff JM,  Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis 2011;2011:847393."},{"key":"B125","series-title":"Can J Surg","first-page":"25","article-title":"Surgical treatment of thymoma","volume":"45","author":"Mehran R","year":"2002","unstructured":"Mehran R, Ghosh R, Maziak D,  Surgical treatment of thymoma. Can J Surg 2002;45:25\u201330."},{"key":"B126","series-title":"Ann N Y Acad Sci","first-page":"526","article-title":"Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis","volume":"505","author":"Howard FM","year":"1987","unstructured":"Howard FM, Lennon VA, Finley J,  Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci 1987;505:526\u2013538."},{"key":"B127","series-title":"Ann Thorac Surg","first-page":"223","article-title":"Management and long-term outcomes of advanced stage thymoma in the United States","volume":"111","author":"Khorfan R","year":"2021","unstructured":"Khorfan R, Bharat A, Odell DD. Management and long-term outcomes of advanced stage thymoma in the United States. Ann Thorac Surg 2021;111:223\u2013230."},{"key":"B128","series-title":"Lung Cancer","first-page":"69","article-title":"Multimodal management of stages III\u2013IVa malignant thymoma","volume":"44","author":"Bretti S","year":"2004","unstructured":"Bretti S, Berruti A, Loddo C,  Multimodal management of stages III\u2013IVa malignant thymoma. Lung Cancer 2004;44:69\u201377."},{"key":"B129","series-title":"Thorac Cardiovasc Surg","first-page":"161","article-title":"Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome","volume":"62","author":"Ried M","year":"2014","unstructured":"Ried M, Potzger T, Sziklavari Z,  Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome. Thorac Cardiovasc Surg 2014;62:161\u2013168."},{"key":"B130","series-title":"J Thorac Oncol","first-page":"S318","article-title":"Evaluation and treatment of stage I and II thymoma","volume":"5","author":"Detterbeck FC","year":"2010","unstructured":"Detterbeck FC. Evaluation and treatment of stage I and II thymoma. J Thorac Oncol 2010;5:S318\u2013322."},{"key":"B131","series-title":"Jpn J Thorac Cardiovasc Surg","first-page":"89","article-title":"Results from surgical treatment for thymoma. 43 years of experience","volume":"48","author":"Murakawa T","year":"2000","unstructured":"Murakawa T, Nakajima J, Kohno T,  Results from surgical treatment for thymoma. 43 years of experience. Jpn J Thorac Cardiovasc Surg 2000;48:89\u201395."},{"key":"B132","series-title":"Hematol Oncol Clin North Am","first-page":"433","article-title":"Fine needle aspiration in the diagnosis of thymic epithelial neoplasms","volume":"22","author":"Wakely PE","year":"2008","unstructured":"Wakely PE. Fine needle aspiration in the diagnosis of thymic epithelial neoplasms. Hematol Oncol Clin North Am 2008;22:433\u2013442."},{"key":"B133","series-title":"J Thorac Oncol","first-page":"S1730","article-title":"Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy","volume":"6","author":"Detterbeck FC","year":"2011","unstructured":"Detterbeck FC, Moran C, Huang J,  Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol 2011;6:S1730\u20131738."},{"key":"B134","series-title":"Cancer","first-page":"1008","article-title":"Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study","volume":"121","author":"Omasa M","year":"2015","unstructured":"Omasa M, Date H, Sozu T,  Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study. Cancer 2015;121:1008\u20131016."},{"key":"B135","series-title":"J Thorac Oncol","first-page":"1357","article-title":"Role of postoperative radiotherapy in nonlocalized thymoma: propensity-matched analysis of Surveillance, Epidemiology, and End Results database","volume":"10","author":"Lim YJ","year":"2015","unstructured":"Lim YJ, Kim HJ, Wu HG. Role of postoperative radiotherapy in nonlocalized thymoma: propensity-matched analysis of Surveillance, Epidemiology, and End Results database. J Thorac Oncol 2015;10:1357\u20131363."},{"key":"B136","series-title":"J Thorac Oncol","first-page":"677","article-title":"Postoperative radiotherapy for completely resected Masaoka\/Masaoka-Koga stage II\/III thymoma improves overall survival: an updated meta-analysis of 4746 patients","volume":"16","author":"Tateishi Y","year":"2021","unstructured":"Tateishi Y, Horita N, Namkoong H,  Postoperative radiotherapy for completely resected Masaoka\/Masaoka-Koga stage II\/III thymoma improves overall survival: an updated meta-analysis of 4746 patients. J Thorac Oncol 2021;16:677\u2013685."},{"key":"B137","series-title":"Interact Cardiovasc Thorac Surg","first-page":"273","article-title":"Which stages of thymoma benefit from adjuvant chemotherapy post-thymectomy?","volume":"15","author":"Attaran S","year":"2012","unstructured":"Attaran S, McCormack D, Pilling J, Harrison-Phipps K. Which stages of thymoma benefit from adjuvant chemotherapy post-thymectomy? Interact Cardiovasc Thorac Surg 2012;15:273\u2013275."},{"key":"B138","series-title":"Radiother Oncol","first-page":"9","article-title":"Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer","volume":"34","author":"Cowen D","year":"1995","unstructured":"Cowen D, Richaud P, Mornex F,  Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol 1995;34:9\u201316."},{"key":"B139","series-title":"J Thorac Dis","first-page":"S228","article-title":"Management of thymic tumors: a European perspective","volume":"6","author":"Ruffini E","year":"2014","unstructured":"Ruffini E, Venuta F. Management of thymic tumors: a European perspective. J Thorac Dis 2014;6(Suppl 2):S228\u2013237."},{"key":"B140","series-title":"Int J Radiat Oncol Biol Phys","first-page":"927","article-title":"Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study","volume":"46","author":"Myojin M","year":"2000","unstructured":"Myojin M, Choi NC, Wright CD,  Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 2000;46:927\u2013933."},{"key":"B141","series-title":"Int J Radiat Oncol Biol Phys","first-page":"651","article-title":"Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer","volume":"32","author":"Mornex F","year":"1995","unstructured":"Mornex F, Resbeut M, Richaud P,  Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys 1995;32:651\u2013659."},{"key":"B142","series-title":"J Thorac Cardiovasc Surg","first-page":"55","article-title":"Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome","volume":"113","author":"Ruffini E","year":"1997","unstructured":"Ruffini E, Mancuso M, Oliaro A,  Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997;113:55\u201363."},{"key":"B143","series-title":"Ann Thorac Surg","first-page":"355","article-title":"Comparison of neoadjuvant chemotherapy followed by surgery to upfront surgery for thymic malignancy","volume":"107","author":"Park S","year":"2019","unstructured":"Park S, Park IK, Kim YT,  Comparison of neoadjuvant chemotherapy followed by surgery to upfront surgery for thymic malignancy. Ann Thorac Surg 2019;107:355\u2013362."},{"key":"B144","series-title":"Eur J Cardiothorac Surg","first-page":"601","article-title":"Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours","volume":"55","author":"Ruffini E","year":"2019","unstructured":"Ruffini E, Guerrera F, Brunelli A,  Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours. Eur J Cardiothorac Surg 2019;55:601\u2013609."},{"key":"B145","series-title":"Hematol Oncol Stem Cell Ther","first-page":"340","article-title":"Multimodality treatments in locally advanced stage thymomas","volume":"2","author":"Hassan M","year":"2009","unstructured":"Hassan M, Seoud DE. Multimodality treatments in locally advanced stage thymomas. Hematol Oncol Stem Cell Ther 2009;2:340\u2013344."},{"key":"B146","series-title":"Thorac Surg Clin","first-page":"107","article-title":"Chemotherapy for thymic tumors: induction, consolidation, palliation","volume":"21","author":"Rajan A","year":"2011","unstructured":"Rajan A, Giaccone G. Chemotherapy for thymic tumors: induction, consolidation, palliation. Thorac Surg Clin 2011;21:107\u2013114, viii."},{"key":"B147","series-title":"Int J Radiat Oncol Biol Phys","first-page":"89","article-title":"Hypofractionated radiation therapy combined with weekly chemotherapy in patients with unresectable or recurrent thymic epithelial tumor: a prospective, single-arm phase 2 study (GASTO-1042)","volume":"114","author":"Chu C","year":"2022","unstructured":"Chu C, Liang Y, Lin X,  Hypofractionated radiation therapy combined with weekly chemotherapy in patients with unresectable or recurrent thymic epithelial tumor: a prospective, single-arm phase 2 study (GASTO-1042). Int J Radiat Oncol Biol Phys 2022;114:89\u201398."},{"key":"B148","series-title":"J Thorac Oncol","first-page":"1715","article-title":"Multidisciplinary tumor board decision making for postoperative radiotherapy in thymic epithelial tumors: insights from the RYTHMIC prospective cohort","volume":"12","author":"Basse C","year":"2017","unstructured":"Basse C, Thureau S, Bota S,  Multidisciplinary tumor board decision making for postoperative radiotherapy in thymic epithelial tumors: insights from the RYTHMIC prospective cohort. J Thorac Oncol 2017;12:1715\u20131722."},{"key":"B149","series-title":"J Thorac Oncol","first-page":"S1749","article-title":"Chemotherapy definitions and policies for thymic malignancies","volume":"6","author":"Girard N","year":"2011","unstructured":"Girard N, Lal R, Wakelee H,  Chemotherapy definitions and policies for thymic malignancies. J Thorac Oncol 2011;6:S1749\u20131755."},{"key":"B150","series-title":"Am Soc Clin Oncol Educ Book","first-page":"e367","article-title":"Systemic treatment of advanced thymic malignancies","author":"Kelly RJ","year":"2014","unstructured":"Kelly RJ. Systemic treatment of advanced thymic malignancies. Am Soc Clin Oncol Educ Book 2014:e367\u2013373."},{"key":"B151","series-title":"J Thorac Oncol","first-page":"1762","article-title":"Systemic therapy in advanced thymic epithelial tumors: insights from the RYTHMIC prospective cohort","volume":"13","author":"Merveilleux Du Vignaux C","year":"2018","unstructured":"Merveilleux Du Vignaux C, Dansin E, Mhanna L,  Systemic therapy in advanced thymic epithelial tumors: insights from the RYTHMIC prospective cohort. J Thorac Oncol 2018;13:1762\u20131770."},{"key":"B152","series-title":"J Thorac Oncol","first-page":"199","article-title":"Surgical management of recurrent thymic epithelial tumors: a retrospective analysis based on the Japanese nationwide database","volume":"10","author":"Mizuno T","year":"2015","unstructured":"Mizuno T, Okumura M, Asamura H,  Surgical management of recurrent thymic epithelial tumors: a retrospective analysis based on the Japanese nationwide database. J Thorac Oncol 2015;10:199\u2013205."},{"key":"B153","series-title":"J Thorac Oncol","first-page":"1936","article-title":"The International Thymic Malignancy Interest Group classification of thymoma recurrence: survival analysis and perspectives","volume":"16","author":"Chiappetta M","year":"2021","unstructured":"Chiappetta M, Lococo F, Zanfrini E,  The International Thymic Malignancy Interest Group classification of thymoma recurrence: survival analysis and perspectives. J Thorac Oncol 2021;16:1936\u20131945."},{"key":"B154","series-title":"Lung Cancer","first-page":"27","article-title":"Prognostic factors after treatment for iterative thymoma recurrences: a multicentric experience","volume":"138","author":"Chiappetta M","year":"2019","unstructured":"Chiappetta M, Zanfrini E, Giraldi L,  Prognostic factors after treatment for iterative thymoma recurrences: a multicentric experience. Lung Cancer 2019;138:27\u201334."},{"key":"B155","series-title":"Cancers (Basel)","first-page":"1559","article-title":"Which is the best treatment in recurrent thymoma? A systematic review and meta-analysis","volume":"13","author":"Chiappetta M","year":"2021","unstructured":"Chiappetta M, Grossi U, Sperduti I,  Which is the best treatment in recurrent thymoma? A systematic review and meta-analysis. Cancers (Basel) 2021;13:1559."},{"key":"B156","series-title":"Interdiscip Cardiovasc Thorac Surg","first-page":"ivae064","article-title":"Updated outcomes of surgical treatment for recurrent thymic tumour: a report from the Japanese nationwide database","volume":"38","author":"Mizuno T","year":"2024","unstructured":"Mizuno T, Chen-Yoshikawa TF, Yoshino I,  Updated outcomes of surgical treatment for recurrent thymic tumour: a report from the Japanese nationwide database. Interdiscip Cardiovasc Thorac Surg 2024;38:ivae064."},{"key":"B157","series-title":"J Thorac Oncol","first-page":"S357","article-title":"The role of chemotherapy in advanced thymoma","volume":"5","author":"Schmitt J","year":"2010","unstructured":"Schmitt J, Loehrer PJ. The role of chemotherapy in advanced thymoma. J Thorac Oncol 2010;5:S357\u2013360."},{"key":"B158","series-title":"J Clin Oncol","first-page":"1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer PJ","year":"1994","unstructured":"Loehrer PJ, Kim K, Aisner SC,  Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994;12:1164\u20131168."},{"key":"B159","series-title":"J Clin Oncol","first-page":"2060","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma GL","year":"2011","unstructured":"Lemma GL, Lee JW, Aisner SC,  Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol 2011;29:2060\u20132065."},{"key":"B160","series-title":"J Clin Oncol","first-page":"814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone G","year":"1996","unstructured":"Giaccone G, Ardizzoni A, Kirkpatrick A,  Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996;14:814\u2013820."},{"key":"B161","series-title":"J Cancer Res Clin Oncol","first-page":"323","article-title":"Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy","volume":"141","author":"Okuma Y","year":"2015","unstructured":"Okuma Y, Saito M, Hosomi Y,  Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy. J Cancer Res Clin Oncol 2015;141:323\u2013331."},{"key":"B162","series-title":"Cancer","first-page":"2010","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer PJ","year":"2001","unstructured":"Loehrer PJ, Jiroutek M, Aisner S,  Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001;91:2010\u20132015."},{"key":"B163","series-title":"Cancer","first-page":"30","article-title":"Chemotherapy for invasive thymoma. A 13-year experience","volume":"68","author":"Fornasiero A","year":"1991","unstructured":"Fornasiero A, Daniele O, Ghiotto C,  Chemotherapy for invasive thymoma. A 13-year experience. Cancer 1991;68:30\u201333."},{"key":"B164","series-title":"J Clin Oncol","first-page":"342","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali PA","year":"2018","unstructured":"Zucali PA, De Pas T, Palmieri G,  Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy. J Clin Oncol 2018;36:342\u2013349."},{"key":"B165","series-title":"Future Oncol","first-page":"2141","article-title":"Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial","volume":"10","author":"Palmieri G","year":"2014","unstructured":"Palmieri G, Buonerba C, Ottaviano M,  Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial. Future Oncol 2014;10:2141\u20132147."},{"key":"B166","series-title":"J Clin Oncol","first-page":"293","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial","volume":"22","author":"Loehrer PJ","year":"2004","unstructured":"Loehrer PJ, Wang W, Johnson DH,  Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial. J Clin Oncol 2004;22:293\u2013299."},{"key":"B167","series-title":"PLoS One","first-page":"e0168215","article-title":"Octreotide LAR and prednisone as neoadjuvant treatment in patients with primary or locally recurrent unresectable thymic tumors: a phase II study","volume":"11","author":"Kirzinger L","year":"2016","unstructured":"Kirzinger L, Boy S, Marienhagen J,  Octreotide LAR and prednisone as neoadjuvant treatment in patients with primary or locally recurrent unresectable thymic tumors: a phase II study. PLoS One 2016;11:e0168215."},{"key":"B168","series-title":"J Thorac Oncol","first-page":"1940","article-title":"A phase II study of pemetrexed in patients with recurrent thymoma and thymic carcinoma","volume":"13","author":"Gbolahan OB","year":"2018","unstructured":"Gbolahan OB, Porter RF, Salter JT,  A phase II study of pemetrexed in patients with recurrent thymoma and thymic carcinoma. J Thorac Oncol 2018;13:1940\u20131948."},{"key":"B169","series-title":"Jpn J Clin Oncol","first-page":"262","article-title":"A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy","volume":"32","author":"Umemura S","year":"2002","unstructured":"Umemura S, Segawa Y, Fujiwara K,  A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy. Jpn J Clin Oncol 2002;32:262\u2013265."},{"key":"B170","series-title":"Lung Cancer","first-page":"111","article-title":"Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): a single-institution experience","volume":"99","author":"Bluthgen MV","year":"2016","unstructured":"Bluthgen MV, Boutros C, Fayard F,  Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): a single-institution experience. Lung Cancer 2016;99:111\u2013116."},{"key":"B171","series-title":"J Clin Oncol","first-page":"2737","article-title":"Treatment of invasive thymoma with single-agent ifosfamide","volume":"17","author":"Highley MS","year":"1999","unstructured":"Highley MS, Underhill CR, Parnis FX,  Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 1999;17:2737\u20132744."},{"key":"B172","series-title":"Lung Cancer","first-page":"29","article-title":"Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review","volume":"135","author":"Konstantina T","year":"2019","unstructured":"Konstantina T, Konstantinos R, Anastasios K,  Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review. Lung Cancer 2019;135:29\u201332."},{"key":"B173","series-title":"Front Oncol","first-page":"583781","article-title":"Case report: lymphocytosis associated with fatal hepatitis in a thymoma patient treated with anti-PD1: new insight into the immune-related storm","volume":"10","author":"Argentiero A","year":"2020","unstructured":"Argentiero A, Solimando AG, Ungaro V,  Case report: lymphocytosis associated with fatal hepatitis in a thymoma patient treated with anti-PD1: new insight into the immune-related storm. Front Oncol 2020;10:583781."},{"key":"B174","series-title":"J Clin Oncol","first-page":"2162","article-title":"Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial","volume":"37","author":"Cho J","year":"2019","unstructured":"Cho J, Kim HS, Ku BM,  Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol 2019;37:2162\u20132170."},{"key":"B175","series-title":"Future Oncol","first-page":"1943","article-title":"Changing pattern of secondary cancers among patients with malignant thymoma in the USA","volume":"14","author":"Kumar V","year":"2018","unstructured":"Kumar V, Garg M, Goyal A,  Changing pattern of secondary cancers among patients with malignant thymoma in the USA. Future Oncol 2018;14:1943\u20131951."},{"key":"B176","series-title":"Cancer","first-page":"2406","article-title":"Thymoma is associated with an increased risk of second malignancy","volume":"92","author":"Pan CC","year":"2001","unstructured":"Pan CC, Chen PC, Wang LS,  Thymoma is associated with an increased risk of second malignancy. Cancer 2001;92:2406\u20132411."},{"key":"B177","series-title":"Cancer","first-page":"3115","article-title":"Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases","volume":"94","author":"Ogawa K","year":"2002","unstructured":"Ogawa K, Toita T, Uno T,  Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer 2002;94:3115\u20133119."},{"key":"B178","series-title":"Cancers (Basel)","first-page":"5085","article-title":"Lymph nodes involvement and lymphadenectomy in thymic tumors: tentative answers for unsolved questions","volume":"13","author":"Brascia D","year":"2021","unstructured":"Brascia D, De Palma A, Schiavone M,  Lymph nodes involvement and lymphadenectomy in thymic tumors: tentative answers for unsolved questions. Cancers (Basel) 2021;13:5085."},{"key":"B179","series-title":"Medicine (Baltimore)","first-page":"e324","article-title":"Long-term follow-up and prognostic factors for advanced thymic carcinoma","volume":"93","author":"Wu JX","year":"2014","unstructured":"Wu JX, Chen HQ, Shao LD,  Long-term follow-up and prognostic factors for advanced thymic carcinoma. Medicine (Baltimore) 2014;93:e324."},{"key":"B180","series-title":"Thorac Surg Clin","first-page":"25","article-title":"Thymic carcinoma: is it a separate entity? From molecular to clinical evidence","volume":"21","author":"Marx A","year":"2011","unstructured":"Marx A, Rieker R, Toker A,  Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. Thorac Surg Clin 2011;21:25\u201331. v\u2013vi."},{"key":"B181","series-title":"Hematol Oncol Clin North Am","first-page":"393","article-title":"Thymic carcinoma: current concepts and histologic features","volume":"22","author":"Moran CA","year":"2008","unstructured":"Moran CA, Suster S. Thymic carcinoma: current concepts and histologic features. Hematol Oncol Clin North Am 2008;22:393\u2013407."},{"key":"B182","series-title":"BMC Cancer","first-page":"349","article-title":"Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center","volume":"14","author":"Okuma Y","year":"2014","unstructured":"Okuma Y, Hosomi Y, Watanabe K,  Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center. BMC Cancer 2014;14:349."},{"key":"B183","series-title":"J Thorac Oncol","first-page":"541","article-title":"Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database","volume":"9","author":"Ruffini E","year":"2014","unstructured":"Ruffini E, Detterbeck F, Van Raemdonck D,  Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol 2014;9:541\u2013548."},{"key":"B184","series-title":"J Thorac Oncol","first-page":"265","article-title":"Thymic carcinoma: 30 cases at a single institution","volume":"3","author":"Yano M","year":"2008","unstructured":"Yano M, Sasaki H, Yokoyama T,  Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol 2008;3:265\u2013269."},{"key":"B185","series-title":"J Thorac Oncol","first-page":"626","article-title":"Postoperative radiation therapy for thymic carcinoma: an analysis of the International Thymic Malignancy Interest Group\/European Society of Thoracic Surgeons database","volume":"19","author":"Rimner A","year":"2024","unstructured":"Rimner A, Ahmad U, Lobaugh SM,  Postoperative radiation therapy for thymic carcinoma: an analysis of the International Thymic Malignancy Interest Group\/European Society of Thoracic Surgeons database. J Thorac Oncol 2024;19:626\u2013635."},{"key":"B186","series-title":"Onco Targets Ther","first-page":"2503","article-title":"Treatment and survival analyses of completely resected thymic carcinoma patients","volume":"8","author":"Mao Y","year":"2015","unstructured":"Mao Y, Wu S. Treatment and survival analyses of completely resected thymic carcinoma patients. Onco Targets Ther 2015;8:2503\u20132507."},{"key":"B187","series-title":"Thorac Cardiovasc Surg","first-page":"153","article-title":"Thymomas and thymic carcinomas: prognostic factors and multimodal management","volume":"62","author":"Moser B","year":"2014","unstructured":"Moser B, Scharitzer M, Hacker S,  Thymomas and thymic carcinomas: prognostic factors and multimodal management. Thorac Cardiovasc Surg 2014;62:153\u2013160."},{"key":"B188","series-title":"Ann Oncol","first-page":"363","article-title":"A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L","volume":"26","author":"Hirai F","year":"2015","unstructured":"Hirai F, Yamanaka T, Taguchi K,  A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L. Ann Oncol 2015;26:363\u2013368."},{"key":"B189","series-title":"Ann Oncol","first-page":"817","article-title":"Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)","volume":"35","author":"Proto C","year":"2024","unstructured":"Proto C, Ganzinelli M, Manglaviti S,  Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671). Ann Oncol 2024;35:817\u2013826."},{"key":"B190","series-title":"JTO Clin Res Rep","first-page":"100738","article-title":"S1701, a randomized phase 2 trial of carboplatin-paclitaxel with and without ramucirumab in patients with locally advanced, recurrent, or metastatic thymic carcinoma","volume":"5","author":"Tsao AS","year":"2024","unstructured":"Tsao AS, Hsieh MH, Koczywas M,  S1701, a randomized phase 2 trial of carboplatin-paclitaxel with and without ramucirumab in patients with locally advanced, recurrent, or metastatic thymic carcinoma. JTO Clin Res Rep 2024;5:100738."},{"key":"B191","series-title":"Lancet Oncol","first-page":"843","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial","volume":"21","author":"Sato J","year":"2020","unstructured":"Sato J, Satouchi M, Itoh S,  Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial. Lancet Oncol 2020;21:843\u2013850."},{"key":"B192","series-title":"Lancet Oncol","first-page":"347","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone G","year":"2018","unstructured":"Giaccone G, Kim C, Thompson J,  Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol 2018;19:347\u2013355."},{"key":"B193","series-title":"Lancet Oncol","first-page":"177","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial","volume":"16","author":"Thomas A","year":"2015","unstructured":"Thomas A, Rajan A, Berman A,  Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol 2015;16:177\u2013186."},{"key":"B194","series-title":"J Thorac Oncol","first-page":"1070","article-title":"STYLE (NCT03449173): a phase 2 trial of sunitinib in patients with type B3 thymoma or thymic carcinoma in second and further lines","volume":"18","author":"Proto C","year":"2023","unstructured":"Proto C, Manglaviti S, Lo Russo G,  STYLE (NCT03449173): a phase 2 trial of sunitinib in patients with type B3 thymoma or thymic carcinoma in second and further lines. J Thorac Oncol 2023;18:1070\u20131081."},{"key":"B195","series-title":"J Thorac Oncol","first-page":"483","article-title":"Durable response in patients with thymic carcinoma treated with pembrolizumab after prolonged follow-up","volume":"16","author":"Giaccone G","year":"2021","unstructured":"Giaccone G, Kim C. Durable response in patients with thymic carcinoma treated with pembrolizumab after prolonged follow-up. J Thorac Oncol 2021;16:483\u2013485."},{"key":"B196","series-title":"Lung Cancer","first-page":"97","article-title":"Everolimus in the treatment of metastatic thymic epithelial tumors","volume":"149","author":"Hellyer JA","year":"2020","unstructured":"Hellyer JA, Ouseph MM, Padda SK, Wakelee HA. Everolimus in the treatment of metastatic thymic epithelial tumors. Lung Cancer 2020;149:97\u2013102."},{"key":"B197","series-title":"Lancet Oncol","first-page":"1287","article-title":"Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Conforti F","year":"2022","unstructured":"Conforti F, Zucali PA, Pala L,  Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial. Lancet Oncol 2022;23:1287\u20131296."},{"key":"B198","series-title":"Lung Cancer","first-page":"98","article-title":"High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: a TYME network study","volume":"176","author":"Conforti F","year":"2023","unstructured":"Conforti F, Pala L, Vivanet G,  High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: a TYME network study. Lung Cancer 2023;176:98\u2013102."},{"key":"B199","series-title":"Lancet Oncol","first-page":"331","article-title":"Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial","volume":"26","author":"Shukuya T","year":"2025","unstructured":"Shukuya T, Asao T, Goto Y,  Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial. Lancet Oncol 2025;26:331\u2013342."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/6\/article-p255.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/6\/article-p255.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/6\/article-p255.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:39:14Z","timestamp":1749631154000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/6\/article-p255.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":199,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2025.0027","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}